본문으로 건너뛰기
← 뒤로

Inhibitory glutamatergic feedback for brain tumor therapy.

1/5 보강
Medical oncology (Northwood, London, England) 📖 저널 OA 11.3% 2022: 0/1 OA 2023: 1/4 OA 2024: 2/10 OA 2025: 9/126 OA 2026: 10/53 OA 2022~2026 2026 Vol.43(2) p. 121
Retraction 확인
출처

Lee RX

📝 환자 설명용 한 줄

Neuronal excitatory activity promotes glioma progression through glutamate-mediated signaling, yet effective ways to counter this using intrinsic brain mechanisms remain undefined.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Lee RX (2026). Inhibitory glutamatergic feedback for brain tumor therapy.. Medical oncology (Northwood, London, England), 43(2), 121. https://doi.org/10.1007/s12032-025-03212-3
MLA Lee RX. "Inhibitory glutamatergic feedback for brain tumor therapy.." Medical oncology (Northwood, London, England), vol. 43, no. 2, 2026, pp. 121.
PMID 41557050 ↗

Abstract

Neuronal excitatory activity promotes glioma progression through glutamate-mediated signaling, yet effective ways to counter this using intrinsic brain mechanisms remain undefined. Repeated low-frequency neuronal stimulation can lead to glutamate buildup and pathway-specific activation of inhibitory presynaptic metabotropic glutamate receptors (mGluRs) within neural circuits. This perspective introduces a hypothesis that this mechanism can disrupt tumor-promoting neuron-glioma interactions. This direction introduces a biologically grounded strategy for a distinctive therapeutic path in precision neuro-oncology.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반